About the Dermatology Drug Development Summit for Inflammatory Skin Diseases

With experienced insights into innovative therapeutic methods and answers to current setbacks, the 5th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases will gather leading pharma biotech and industry stakeholders to examine transformational techniques to continually develop the ever-increasing success of the dermatology drug development world.

150+ Attendees, 5+ Hours of Networking, 50+ Leading Organisations, 4 Exclusive pre-Conference Workshops, 30+ Insightful Presentation by Industry Experts

Join us this November as the trailblazers of dermatology drug development, from the likes of Galderma, Sanofi, Eli Lilly, Leo Pharmaand Pfizer come together to accelerate and advance therapeutic innovation within dermatology whilst challenging the industry’s biggest obstacles.

This meeting will increase the growth of your dermatology drug pipeline with comprehensive debates across several subjects within dermatology drug development, including but not limited to: 

Bullet-point

Regulatory Perspective of the Current Dermatology Drug Development Landscape 

Bullet-point

Discovery, Preclinical Development & Translational Research

Bullet-point

Clinical Development and Research

Bullet-point

Patient-Centricity: The Power of the Patient

Bullet-point

Topical Drug Development and Formation

Joining this year’s meeting will provide distinct insights and equip you with techniques to optimize the true potential of this rapidly growing industry and develop further successful dermatology therapies. 

Want to learn more?

Ready to attend?

Don't Just Take Our Word For It...

“I was able to get something out of each presentation. It was a total success in my opinion.”

GlaxoSmithKline

"A very good meeting in terms of presentation topics, interactive workshops, and networking"

Celgene

"The talks were high quality and the interaction among participants was excellent"

Genentech